ArticleNeurology and therapy2023

Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.

Amir Abbas Tahami Monfared et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.